• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Pituitary tumors: pathophysiology, clinical manifestations and
Pituitary tumors: pathophysiology, clinical manifestations and

... all. They are reported to occur more frequently in women than in men, particularly between the second and third decades of life, when the ratio is estimated to be 10:1. After the fifth decade of life, the frequency of prolactinomas is similar in both sexes (Mindermann & Wilson 1994). Prolactinomas va ...
Levofloxacin for the Treatment of Respiratory Tract Infections Based
Levofloxacin for the Treatment of Respiratory Tract Infections Based

... similar (> 125; target ratio for Pseudomonas aeruginosa), whereas the ratios for gatifloxacin and moxifloxacin were significantly lower. Levofloxacin and ciprofloxacin are considered to have comparable antipseudomonal activity on the basis of in vitro activity and therefore either may be used as an ...
Hypodermoclysis - Nursing Home Help
Hypodermoclysis - Nursing Home Help

... During the study period, one incidence of marked local edema occurred, which resolved without diuretic administration after site rotation. All other infusions ...
FACTS - American Heart Association
FACTS - American Heart Association

... follow the intensity of the drug regimen or continue to take their drugs through the duration of the prescription. There are a variety of potential reasons for this including poor communications between healthcare providers and patients, fear of side effects, high medication costs, interaction with ...
Rheumatology Highlights
Rheumatology Highlights

... standard treatment. However, this drug has long-term alkylating side effects, and it would be desirable to avoid the alkylating agents altogether. These are impressive results. They achieved remission in 13 of 17 patients at 6 months without alkylating therapy. At 18 months, there were four relapses ...
Abstract
Abstract

... Kruize, Floris PJG Lafeber, Joel AG van Roon. University Medical Center Utrecht, Utrecht, Netherlands Background In patients with primary Sjögren’s syndrome (pSS) local T cell-driven inflammation can contribute to destruction of exocrine glands associated with clinical symptoms of dryness. Evidence ...
Glomerulonephritis * Keith K. Lau, MD , Robert J. Wyatt, MD, MS
Glomerulonephritis * Keith K. Lau, MD , Robert J. Wyatt, MD, MS

... Currently, treatment of IgAN in adolescents is not guided by results of welldesigned randomized control trials (RCTs) that employ appropriate outcome measures [38]. The first choice for treatment of hypertension is an ACEi. Adolescents with a urine protein-to-creatinine ratio greater than 1.0 after ...
Perform and interpret CSF Examinations
Perform and interpret CSF Examinations

... - Exception: therapeutic use of lumbar puncture to reduce ICP  Infections - Skin infections at puncture site may cause sepsis  Abnormal respiratory pattern -Hypertension with bradycardia and deteriorating consciousness -Vertebral deformities (scoliosis or kyphosis), in hands of an inexperienced ph ...
Review article: the current pharmacological therapies for hepatic
Review article: the current pharmacological therapies for hepatic

... Based on the principle that intestinal-derived ammonia contributes to the pathogenesis of hepatic encephalopathy, current therapeutic approaches are directed at reducing bacterial production of ammonia and enhancing its elimination. Non-absorbable disaccharides are first-line therapy for hepatic enc ...
Adempas - AZBlue
Adempas - AZBlue

... artery, pulmonary vein, or pulmonary capillaries, leading to complaints of shortness of breath, dizziness, fainting, fatigue, chest pain, palpitations, leg swelling and other symptoms. PH is a severe progressive disease with markedly decreased exercise tolerance, heart failure and ultimately death. ...
Pharmacy Services - Blue Cross and Blue Shield of New Mexico
Pharmacy Services - Blue Cross and Blue Shield of New Mexico

... Requests for drug preauthorization are to be directed to the Blue Cross Community Centennial Pharmacy Department. Changes to the list are published in the Blue Review provider newsletter and on the BCBSNM website (www.bcbsnm.com). Current BCBSNM Medical Policy regarding “off-label use of FDA approve ...
Intracranial Cryptococcosis in lmmunocompromised Patients:
Intracranial Cryptococcosis in lmmunocompromised Patients:

... patient with pattern 3 MR lesions (miliary enhancing nodules), CT scans showed foci of punctate calcification in the parenchyma and leptomeninges without enhancing lesions. The last two patients, who had pattern 4 MR lesions (mixed pattern), had CT scans that were unremarkable. One of these showed c ...
重症肌无力 - 文档下载
重症肌无力 - 文档下载

... to cholinergic stihttp://doc.guandang.net/bda9fb15516c2139b7336de75.htmlmulation of muscarinic AChR on smooth muscle and autonomic glands. They occur in about one-third of the patients.30,31 The most frequent are gastrointestinal disorders, such as gut hypermo-tility, which may lead to abdominal pai ...
hyponatremia - WordPress.com
hyponatremia - WordPress.com

... Hyperacute hyponatremia Developed over just a few hours due to a marked increase in water intake (self-induced water intoxication, as may be seen in marathon runners, psychotic patients, and users of ecstasy) Sub-acute : Developed within the previous 24 to 48 hours. Chronic hyponatremia: Present for ...
Introduction - PMR-GCA UK North East Support
Introduction - PMR-GCA UK North East Support

... Although PMR has very characteristic symptoms, there are number of other autoimmune, infectious, endocrine and malignant disorders which may present with polymyalgia like symptoms. It is important to make the diagnosis in a safe step-wise manner based on ‘essential’ symptoms such as bilateral should ...
Neurosarcoidosis MD , Kenneth L. Weiss, MD *
Neurosarcoidosis MD , Kenneth L. Weiss, MD *

... treatment for the sarcoidosis [60], or other conditions. Fig. 2 reveals the MR image of a patient followed at our clinic for pulmonary and cutaneous sarcoidosis. This patient had discontinued systemic therapy for more than 5 years when she presented with ataxia, and the MR imaging revealed a cerebel ...
Chiropractic - Squarespace
Chiropractic - Squarespace

... in symptoms, function, disability, and satisfaction, and were superior to booklet in terms of symptoms and satisfaction. However, McKenzie did not reduce recurrences or long-term utilization of health care.” ...
Management of Alcohol Withdrawal Delirium
Management of Alcohol Withdrawal Delirium

... 1966, from review articles, and from textbooks were also examined and included when appropriate. Members of the working group, using a structured data collection form, abstracted all articles meeting the initial inclusion criteria. Articles identified as prospective controlled trials with patients m ...
Guidelines for the Management of Adverse Drug
Guidelines for the Management of Adverse Drug

... 1) if the original reaction was severe, begin the rechallenge with 1/10 the day 1 dose listed in Table 1 (e.g. INH 5mg) b. if a reaction does not occur after the day 1 dose, increase the INH to 300mg on day 2 c. if a reaction does not occur after the day 2 dose, continue INH 300mg q day d. continue ...
Clinical Commissioning Policy: Trigeminal Neuralgia April 2013
Clinical Commissioning Policy: Trigeminal Neuralgia April 2013

... (or from studies where the study design has not been described) and as such any conclusions regarding specific treatment recommendations must be viewed cautiously. This management algorithm suggests treatment with SRS or Percutaneous Retrogasserian Rhizotomy (PRR, includes PGR, PCB and PRTR) in pati ...
Koontz_bu_0017N_10579 - OpenBU
Koontz_bu_0017N_10579 - OpenBU

... and adolescents, these prominent scars can have a significant impact on quality of life (QOL). Children afflicted with striae were more susceptible to depression, loss of selfesteem, emotional distress, eating disorders (Strumia, 2005), and in some cases, body dysmorphic disorder (Tedeschi, Dall’Ogl ...
Amiodarone IV: Indications, Dosing, Clinical Studies
Amiodarone IV: Indications, Dosing, Clinical Studies

... • Cordarone I.V. should be administered only by physicians who are experienced in the treatment of life-threatening arrhythmias, who are thoroughly familiar with the risks and benefits of Cordarone therapy, and who have access to facilities adequate for monitoring the effectiveness and side effects ...
Transformational Systemic Therapy Level II Advanced
Transformational Systemic Therapy Level II Advanced

... This program is for counselors and therapists who have completed a Transformational Systemic Therapy Level II training program offered by the Satir Institute of the Pacific (or an equivalent program approved by Kathlyne Maki-Banmen, Director of Training) who are presently working with clients in a c ...
Product Information: Pertuzumab
Product Information: Pertuzumab

... PERJETA was given intravenously as an initial dose of 840 mg, followed every three weeks thereafter by a dose of 420 mg. Trastuzumab was given intravenously as an initial dose of 8 mg/kg, followed every three weeks thereafter by 6 mg/kg. Patients were treated with PERJETA and trastuzumab until disea ...
What Should the Systolic Blood Pressure Treatment Goal be in
What Should the Systolic Blood Pressure Treatment Goal be in

... guidelines recommended lowering the SBP to less than 150 mmHg unless these patients have diabetes mellitus or chronic kidney disease when a goal of less than 140 mmHg can be considered [9]. The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study is an observational study of risk ...
< 1 ... 199 200 201 202 203 204 205 206 207 ... 462 >

Management of multiple sclerosis



Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report